TABLE 2.

Characteristics of the operation procedure, infection indices, and fetal outcome

Parameters	Units category	Experimental (N = 104)	Placebo (N = 108)	p
Uterine incision lancination	No	100	107	0.161
	Yes	4	1
Uterine suture	Double layer only	98	107	0.136
	Double layer + B‐lynch	5	1
	Double layer + balloon	1	0
Operation duration	min	35.3 ± 7.3	35.1 ± 7.3	0.859
	<30	12	15	0.796
	≥30, <40	63	67
	≥40, <60	28	24
	≥60	1	2
Blood loss	mL	228.4 ± 63.8	231.1 ± 193.9	0.893
Hemoglobin post‐CS	g/L	113.0 ± 12.7	112.8 ± 12.2	0.945
	<113	50	52	0.992
	≥113	54	56
WBC count post‐CS	×109/L	12.8 ± 2.8	12.9 ± 2.7	0.731
	<10	17	14	0.739
	≥10, <15	64	67
	≥15	23	27
NEU% post‐CS	%	80.9 ± 4.2	81.5 ± 4.1	0.274
	<75	6	6	0.461
	≥75, <90	81	77
	≥90	17	25
hsCRP post‐CS	mg/L	48.0 ± 29.9	50.0 ± 31.7	0.651
	<50	64	63	0.619
	≥50	37	42
		3	3
CRP ratio	(Post/pre‐CS)	5.8 ± 4.9	6.1 ± 5.2	0.616
		7	10
Procalcitonin post‐CS	μg/L	0.14 ± 0.17	0.11 ± 0.08	0.069
	<0.05	20	18	0.482
	≥0.05	75	87
		9	3
Procalcitonin ratio	(Post/pre‐CS)	2.2 ± 2.2	2.0 ± 1.3	0.391
		13	7
Vaginal secretion culture pre‐CS	Negative	56	57	0.725
	Mycoplasma	40	46
	Others	7	5
Uterine cavity culture in‐CS	Negative	87	94	0.426
	Mycoplasma	8	9
	Escherichia coli etc.	8	4
Body temperature post‐CS		36.83 ± 0.25	36.80 ± 0.29	0.370
	<37°C	77	80
	≥37°C, <37.5°C	27	27
	≥37.5°C	0	1
Antibiotics doses before randomization	Doses	1.8 ± 2.6	1.9 ± 2.7	0.783
Antibiotics doses after CS	Doses	1.0 ± 2.0	1.4 ± 2.9	0.222
Antibiotics used after CS %	Cases/No.* %	24	31.5	0.228
In‐hospital	Days	4.09 ± 0.46	4.16 ± 0.63	0.353
APGAR score 1 min	10	100	98	0.491
	9	1	1
	8	2	4
	7	1	4
	4	0	1
APGAR score 5 min	10	104	105	0.231
	9	0	2
	7	0	1
Fetal body weight	g	3423.9 ± 414.8	3437.5 ± 429.2	0.816
Fetal macrosomia		95	101	0.549
		9	7
Days from CS to follow up	Days	75.4 ± 32.7	75.4 ± 32.0	0.994
	≥42, <66	50	55	0.680
	≥66	54	53

Note: Data are mean ± standard deviation, or n.

Abbreviations: CS, cesarean Section; hsCRP, hypersensitive C‐reactive protein; NEU%, percentage neutrophils; WBC, white blood cell.